POLYPLEXNSEPolyplex Corporation Limited· PackagingMediumNeutral
Announced Sat, 31 May · 15:04 IST

Polyplex Corporation Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

POLYPLEX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Polyplex Corporation filed its investor presentation for Q4 FY25 and FY25. For Q4 FY25, sales revenue rose 4% QoQ to INR 1,736 crores ($200 million) on 1% volume growth to 88,226 MT, while normalized EBITDA jumped 10% QoQ to INR 187 crores ($22 million) at an 11% margin. PAT, however, turned negative at -INR 9 crores due to an unrealized FX loss of INR 105 crores on foreign currency loans. For the full year FY25, revenue grew 1% YoY to INR 6,869 crores ($812 million) with volumes up 9% to 342,685 MT and normalized EBITDA up 49% YoY to INR 752 crores ($89 million). The company outlined $76.5 million in growth capex including a new BOPET film line in India ($58 million) targeted for H2 FY26-27, and guided Q1 FY26 normalized EBITDA at $26 million. Polyplex remains ranked #2 globally (ex-China) in Thin BOPET film capacity, with 7 plants across 5 countries and a stable India AA- credit rating.

Likely market impact

FY25 saw a strong 49% jump in normalized EBITDA showing margin recovery, supported by better specialty mix and D-PAC sales growth, which should be viewed positively by shareholders. However, the negative Q4 PAT due to large FX losses on inter-company loans is a watch item. The capex pipeline and margin improvement guidance from US expansion and D-PAC sales suggest management is confident in continued earnings momentum.